Table 1.
Perioperative characteristics of HCC patients
| Age (years) |
70 ± 9 |
| Gender (male/female) |
45/16 |
| HBV/HCV/NBC |
12/32/15 |
| Child-Pugh class (A/B) |
56/5 |
| Diabetes mellitus (+/−) |
8/53 |
| WBC count (/μl) |
5,000 ± 1,319 |
| Lymphocyte count (/μl) |
1,484 ± 580 |
| ICGR15 (%) |
16.1 ± 7.8 |
| Albumin (g/dl) |
3.8 ± 0.4 |
| Total bilirubin (mg/dl) |
0.81 ± 0.21 |
| Cholinesterase (U/l) |
232 ± 64 |
| Triglyceride (mg/dl) |
85 ± 43 |
| Prothrombin time (%) |
92 ± 12 |
| Platelet count (×104/μl) |
15 ± 8 |
| AST (U/l) |
43 ± 27 |
| ALT (U/l) |
42 ± 28 |
| RBP (mg/dl) |
3.3 ±1.4 |
| TTR (mg/dl) |
16 ±6 |
| BTR |
5.09 ± 1.46 |
| AFP (ng/ml) |
994 ± 5,028 |
| PIVKA-II (mAU/ml) |
1,283 ± 2,209 |
| Esophageal and/or gastric varices (+/−) |
15/46 |
| Surgical procedure (limited/anatomic) |
35/26 |
| Operation time (min) |
329 ± 130 |
| Operative blood loss (ml) |
1,011 ± 1,351 |
| Blood transfusion (+/−) |
9/52 |
| Tumor size (cm) |
4.42 ± 4.09 |
| Associated liver disease |
|
| (normal/fibrosis or hepatitis/cirrhosis) |
9/30/22 |
| Morbidity (+/−) | 5/56 |
Data represent the mean ± standard deviation or the number of patients. HBV hepatitis B virus, HCV hepatitis C virus, NBC non-hepatitis B or C virus, WBC white blood cell, ICGR15 indocyanine green retention rate at 15 min; ALT alanine aminotransferase, RBP retinol binding protein, TTR transthyretin, BTR branched chain amino acid/tyrosine ratio, AFP α-fetoprotein, PIVKA-II protein induced by vitamin K absence/antagonism-II.